Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

Chemistry World March 19, 2013 Simon Hadlington	Global AstraZeneca restructuring will cost 1600 jobs The company's global research blueprint will now be centered on the creation of three 'strategic R&D centers' for small molecules and biologics, to be based in Cambridge in the UK, Gaithersburg in Maryland, US, and Molndal in Sweden, to be completed by 2016.
Chemistry World April 2, 2013 Bibiana Campos Seijo	More job cuts... The news came in that AstraZeneca is to invest 330 million pounds in a new strategic R&D center and global headquarters in Cambridge, UK. Unfortunately, there is also a negative angle to this story.
Chemistry World May 7, 2013 Phillip Broadwith	AstraZeneca site to become biotech hub The first three companies have already moved in, and more will hopefully follow to fill the space left by AZ as it relocates to Cambridge, UK.
Chemistry World April 3, 2014 Emma Stoye	Pharma giants plan new public--private collaborations AstraZeneca will partner with the Medical Research Council, in its new Cambridge site, while the Wellcome Trust Genome Campus will host a new center for target validation studies, jointly founded with the European Bioinformatics Institute and GlaxoSmithKline.
Chemistry World January 30, 2014 Phillip Broadwith	AstraZeneca ends R&D in India Pharmaceutical firm AstraZeneca is quitting its R&D site in Bangalore, India.
Chemistry World December 10, 2014	Big pharma opens up abandoned drugs Sixty eight stalled pharmaceutical compounds are being made available for academic research through the UK Medical Research Council.
Chemistry World April 29, 2014 Phillip Broadwith	Pfizer courts AstraZeneca megamerger US-based pharma behemoth Pfizer has publically announced its intention to make a merger offer to the UK's AstraZeneca, in a deal valued at around $100 billion.
Chemistry World May 14, 2014 Andy Extance	Pfizer presses hard for AstraZeneca deal US pharma giant Pfizer is battling a backlash of suspicion and hostility across the world over its attempts to acquire its UK-headquartered rival AstraZeneca.
Chemistry World May 28, 2014 Phillip Broadwith	Time called on Pfizer -- AstraZeneca deal Pfizer's pursuit of a pharmaceutical megamerger has concluded with the US giant withdrawing its final offer two hours before the deadline set by the UK's takeover rules.
Chemistry World February 2, 2012 Andrew Turley	AstraZeneca to cut 7300 more jobs UK drugmaker AstraZeneca has announced plans to cut a further 7300 jobs to make annual savings of $1.6 billion by the end of 2014, a move that will cost the company $2.1 billion in the near term.
Chemistry World May 19, 2014 Phillip Broadwith	AstraZeneca refuses Pfizer's 'final' offer The US giant has described this proposal, valuing AZ at 70 billion pounds, as 'final' and says it 'cannot be increased'.
Bio-IT World May 19, 2004 Barbara Depompa	Turning Sugar into Science The landmark building that housed the New England Confectionery Company in Revere, Mass. is being transformed into the new headquarters for the Novartis Institutes for BioMedical Research.
Chemistry World February 2, 2015 Emma Stoye	UK announces 40m fund for synthetic biology The UK government has said it will invest 40 million pounds in synthetic biology over the next five years, 32 million of which will be used to establish three new research centers.
Chemistry World November 22, 2013 Emily James	100 million for cancer research centers Cancer Research UK has invested 100 million pounds in 15 innovative research centers, acquiring high level expertise to solve the latest challenges in cancer.
The Motley Fool May 15, 2006 Brian Gorman	AstraZeneca's Peer-Pressure Purchase The drug company seems to be paying a lot for Cambridge Antibody. Perhaps AstraZeneca didn't want to be left behind as its rivals bought up biotech technology -- but in its haste, it may be paying a steep price for what it's getting. Investors, take note.
Chemistry World April 28, 2014 Emma Stoye	Scientists asked how to spend UK science cash The UK government is asking the scientific community what the portion of the science budget set aside for infrastructure should be spent on over the next five years.
Chemistry World April 16, 2010 Sean Milmo	Ineos starts UK chemicals exodus Ineos's decision to relocate its headquarters to Switzerland because of corporate taxation concerns may spark an exodus of chemical and pharmaceutical companies from having their headquarters in the UK.
Chemistry World December 5, 2013 Phillip Broadwith	Merck KGaA snaps up electronic materials specialist The speciality chemicals arm of Merck KGaA has agreed to buy out AZ Electronic Materials for 1.6 billion pounds in cash.
Chemistry World October 25, 2013 Emily James	AstraZeneca to close environmental lab and cut 71 jobs The 71 employees at the Brixham Environmental Laboratory in Devon, UK. will lose their jobs in March 2014, as the laboratory's environmental operations are not a core part of the company's strategy to develop innovative new medicines.
Chemistry World December 13, 2013 Maria Burke	UK overtakes US on research quality metric The UK has overtaken the US and now ranks first in one indicator of research quality, according to a new report commissioned by the UK's Department of Business, Innovation and Skills.
Chemistry World April 23, 2013 Emma Stoye	Invest in research or be left behind, UK academies warn The UK's four national academies have called on the government to increase investment in research over the next decade or risk being overtaken by international competitors.
Chemistry World February 10, 2015 Emma Stoye	Science societies urge next UK government to invest more in research The next UK government should invest twice as much in research, according to a joint statement released by the National Academies.
Chemistry World July 15, 2008 Hepeng Jia	Testing Times for New Liver Drug AstraZeneca is set to start clinical trials of a liver cancer drug developed for Chinese patients.
Chemistry World June 4, 2015 Phillip Broadwith	Takeda to consolidate vaccines business in Boston Japanese pharma firm Takeda plans to close three US sites and move the headquarters of its vaccines business unit to the pharmaceutical hub in the Boston and Cambridge area of Massachusetts.
Chemistry World July 2010	Biotech - onwards and upwards The end of the UK's Eastern Region Biotechnology Initiative marks the beginning of a new era, writes Harriet Fear, former chief executive of Erbi
Chemistry World April 24, 2007 Victoria Gill	AstraZeneca Scoops up $15.6 Billion Vaccine Business AstraZeneca has joined the race to scoop up acquisition opportunities in the biologics sector with a $15.6 billion deal to buy U.S. vaccines and biotechnology company MedImmune.
Chemistry World March 26, 2014 Phillip Broadwith	AstraZeneca boosts open innovation efforts Astrazeneca has launched a new web portal, bringing together new and existing open innovation programs. The aim is to make collaboration with academics, other companies, governments and non-government organizations easier.
Chemistry World March 21, 2013 Phillip Broadwith	AstraZeneca partners with Moderna for $240 million Moderna has developed a way to use messenger RNA (mRNA), the molecule cells use to turn DNA into proteins, to stimulate the production of specific proteins in cells where disease has diminished or eliminated their ability to do so.
Chemistry World September 2007 Ian Pearson	Comment: Global Science Matters The UK's new science minister says that an international perspective is vital for scientific growth.
Pharmaceutical Executive December 1, 2011	UK Report: Keep Calm and Carry On ... Differently Even as the global economic roller coaster affects one of the country's dearest public institutions, the National Health Service, there is still reason for optimism in these times of austerity.
Chemistry World March 2, 2015 Phillip Broadwith	AstraZeneca to spin off anti-infectives research The new company's principal asset will be the novel gyrase inhibitor AZD0914, which is currently in Phase II clinical trials for treating gonorrhea.
Chemistry World March 20, 2008 Richard Van Noorden	UK Drug Firms to Slash Research and Jobs The UK pharmaceutical industry is expecting to cut jobs and investment in R&D following an alarming slump in confidence in the UK market.
Chemistry World September 10, 2015 Matthew Gunther	Research bodies urge UK government to protect science funding Nearly 200 research organizations have signed an open letter urging the UK government to protect science funding in the 2015 UK spending review.
Chemistry World February 18, 2011 Carol Stanier	Speed dating for pharmaceuticals A simple analysis of hydrogen bond strengths finds the best crystallisation partners for drugs, say UK scientists.
Chemistry World September 13, 2012 Andy Merritt	Chemical biology comes of age Historically strongest in the US, chemical biology has become increasingly important worldwide, but for many years researchers at the chemistry -- biology interface have struggled to establish their discipline
Chemistry World February 20, 2013 Laura Howes	UK-India projects launched To coincide with the prime minister's visit to India, UK universities have announced a series of research partnerships and scholarships intended to boost the trade and education links between the UK and India.
The Motley Fool November 23, 2004 Brian Gorman	AstraZeneca Buys Into Cambridge Antibody Cambridge Antibody scored a new alliance, although the deal threatens to make it a house divided.
Chemistry World March 9, 2010 Anna Lewcock	Fund science or risk economic downfall Leading researchers and former science ministers have today warned the UK government it risks 'throwing away' years of investment unless the UK keeps pace with science funding levels in other countries.
Chemistry World December 8, 2015 Jennifer Newton	Pfizer to close Cambridge pain outpost Pfizer plans to shut down its Neusentis site on the outskirts of Cambridge, UK, in a move that will eliminate up to 120 jobs.
Chemistry World December 11, 2006 Richard Van Noorden	Unique Teaching Laboratory Goes Online A remote-controlled chemical laboratory that can be operated through the internet was unveiled recently. The system allows chemical engineering students anywhere in the world to operate a real-life laboratory without costly equipment.
Chemistry World July 1, 2014 Emma Stoye	UK government announces 400m innovation fund The UK government's Technology Strategy Board has set aside 400 million pounds to help companies commercialize new technologies in the 2014 -- 15 financial year.
Chemistry World July 2010	Supporting science The Wellcome Trust is one of the largest science funding bodies in the world. Sir Mark Walport, the trust's director, tells Phillip Broadwith how it spends its money
Chemistry World July 31, 2014 Phillip Broadwith	AstraZeneca stocks respiratory and cancer pipelines AstraZeneca has agreed to buy Spanish firm Almirall's respiratory drug assets for $875 million up front, plus up to $1.2 billion in performance milestone payments.
Chemistry World February 6, 2014 Patrick Walter	Clouds on the horizon for UK science The UK needs to up its game to keep up with the rest of the continent when it comes to science, Europe's research chief has said.
Chemistry World January 7, 2013 Andrew Turley	Wellcome Trust launches investment wing The Wellcome Trust has provided 200 million pounds to launch an investment company that aims to support innovative healthcare businesses with the potential to transform the markets in which they operate.
Chemistry World November 25, 2010 Mike Brown	Capping scientific migrants A new UK immigration cap could bias against researchers looking to come to the UK.
Chemistry World February 2, 2011 Andy Extance	Pfizer to close historic UK site Most of the 2400 people employed at the Pfizer site in Sandwich, UK, will be made redundant over the next 18-24 months as the US pharma giant restructures its research operations.
Chemistry World October 1, 2015 Phillip Broadwith	Human capital The wave of mergers and acquisitions -- particularly in the pharmaceutical sector, but also to some degree in fine and specialty chemicals -- highlights the growing importance of small and medium-sized enterprises in the business landscape.
Chemistry World June 2007 Yfke Hager	Careers: Sheer Determination After an unconventional start to his career, Graham Ruecroft co-founded a firm that recently earned him his second RSC innovation award. Here's an interview.
Chemistry World May 23, 2011 Ned Stafford	Report: Free researchers from copyright shackles A new government-commissioned review of UK copyright laws is recommending major changes that would have not only a major impact on the music and film industry, but also on scientific research.